REGENGLOBALUK LIMITEDActive

Company number 09455017Private limited companyIncorporated 2015

Key figures

£28,173+41.3%
Net assets 2025/26
+10.9%
Average annual growth 2020/21–2025/26
010 k20 k30 k40 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, REGENGLOBALUK LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
025 k50 k75 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand15,18812,6094,51114,75143,417
Total assets55,26830,78163,20649,73454,422
Total liabilities—————
Net assets / total equity35,86825,47529,90319,93628,173
Average number of employees10000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: REGENGLOBALUK LIMITED

Company

REGENGLOBALUK LIMITED is a private limited company registered with Companies House under company number 09455017. It was incorporated on 24 Feb 2015. Its status is active. The registered office is in Gillingham (ME8). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500), retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749).

Accounts

The latest accounts in the database are for 2025/26 (period ending 28 Feb 2026); the company files small company accounts (filleted). Net assets were £28,173, up 41.3% on the previous year. Cash at bank and in hand was £43,417. The company had an average of 0 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Nov 2027. The next confirmation statement is due by 10 Mar 2027.